Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Big thanks and Question to attendees on licensing rate futures

Regarding the PPT chart with the royalty rates…There were no numbers on the Y axis (vertical).  Thus, it was simply intended to be a pictorial that painted the picture of a decent hockey stick pattern  with royalty rates increasing as they moved towards the upper right of the chart over time.

Leckrone made it very clear, we are NOT going after the chip manufacturers.  We are  currently going after the system (box) folks.  According to Dan L., there are fewer aggregate dollars across the limited set of chip manufactures.  He said that we don’t want to “burn” our royalty opportunity on the chip manufacturers.   And that there are many more dollar opportunities  across those who are adding value down stream from the chip manufacturers. He went on to state that Intel and AMD were special “1-time” deals, prior to the development of the  MMP approach; the foreseeable future will consist only of MMP engagements. As SGE stated, this should help explain the partial MMP purchase by NEC. 

Share
New Message
Please login to post a reply